IIM
BRNS

Ipswich Investment Management’s Barinthus Biotherapeutics BRNS Stock Holding History

Ipswich Investment Management’s Portfolio BRNS Stock Details BRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17,575
Closed -$21.2K – 188
2024
Q4 		$21.2K Sell
17,575
-5,000
-22% -$5.82K 0.01% 185
2024
Q3 		$26.9K Sell
22,575
-500
-2% -$671 0.01% 191
2024
Q2 		$32.3K Hold
23,075
– – 0.01% 184
2024
Q1 		$54.9K Hold
23,075
– – 0.01% 195
2023
Q4 		$85.1K Sell
23,075
-4,000
-15% -$13.5K 0.02% 185
2023
Q3 		$83.7K Hold
27,075
– – 0.02% 183
2023
Q2 		$55.8K Hold
27,075
– – 0.01% 188
2023
Q1 		$60.6K Buy
27,075
+5,700
+27% +$15.9K 0.02% 186
2022
Q4 		$50.2K Sell
21,375
-2,100
-9% -$5.35K 0.01% 179
2022
Q3 		$75K Sell
23,475
-16,500
-41% -$70.1K 0.02% 169
2022
Q2 		$178K Sell
39,975
-12,400
-24% -$59.7K 0.05% 173
2022
Q1 		$272K Buy
52,375
+1,000
+2% +$8.06K 0.07% 167
2021
Q4 		$571K Sell
51,375
-100
-0.2% -$1.26K 0.13% 122
2021
Q3 		$810K Buy
51,475
+8,200
+19% +$125K 0.21% 106
2021
Q2 		$726K Buy
+43,275
New +$640K 0.19% 111

Other funds holding BRNS

MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
JHU
Johns Hopkins University Baltimore, Maryland $1.38B AUM 9.48% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ipswich Investment Management's BRNS Position: Q1 2025 in Review

Ipswich Investment Management sold out of Barinthus Biotherapeutics (BRNS) in Q1 2025, closing a stake of 17,575 shares — an estimated $21.2K sold.

Ipswich Investment Management first reported a position in BRNS in Q2 2021 and held it in 15 quarters. The position peaked at $810K in Q3 2021. 15 funds tracked by Wall St. Rank hold BRNS as of Q1 2025.

  • Ipswich Investment Management reported no remaining Barinthus Biotherapeutics position as of Q1 2025 after selling out during the quarter.
  • Ipswich Investment Management sold 17,575 Barinthus Biotherapeutics shares in Q1 2025, an estimated $21.2K.
  • Ipswich Investment Management first reported a position in Barinthus Biotherapeutics in Q2 2021 and held it in 15 quarters.
  • Ipswich Investment Management's Barinthus Biotherapeutics position peaked at $810K in Q3 2021.
  • 15 funds tracked by Wall St. Rank held Barinthus Biotherapeutics as of Q1 2025.

Based on Ipswich Investment Management's 13F filing for Q1 2025, filed 16 Apr 2025.